CV Lattes
ResearcherID
ORCID
Secretaria da Saúde (São Paulo - Estado). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Instituto do Coração Professor Euryclides de Jesus Zerbini (INCOR) (Institutional affiliation for the last research proposal) Birthplace: Brazil
Level 3 Associate Professor at the Faculty of Medicine of the University of São Paulo (FMUSP), Director of the Acute Coronary Disease Unit and Supervisor of the Cardiology Residency Program of the Instituto do Coração - InCor / HCFMUSP. Obtained his Doctorate in 1992 from the State University of Campinas and his PhD in 1995 from the University of São Paulo. Ex- President of the State of São Paulo Society of Cardiology (SOCESP) and Scientific Director of the Brazilian Society of Cardiology (SBC), is Reviewer / Member of the Editorial Board in several national and international journals, being Associated Editor of the International Journal of Cardiology. He has more than 385 original articles / book chapters published, in addition to being a ?senior? editor in 4 books. Member of Steering/Executive Committees in more than 65 national and international multicentre studies, his area of interest covers different aspects of coronary artery disease, such as new drugs, pathophysiology, platelet aggregation and anti-aggregation and epidemiology, among others. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Introduction: epidemics caused by the Influenza virus are recognized for their great impact on public health. The identification of a new coronavirus strain (SARS-CoV-2) with pandemic spread has brought new challenges for diagnosis, control and therapy. The rapid and low-cost diagnosis of SARS-CoV-2 and influenza infections may allow the adoption of measures to control transmissibility bo…
The recent demonstration that high on-treatment platelet reactivity is a common phenomenon, and that these patients have a worse prognosis when undergoing coronary angioplasty, along with the development of new devices for assessing platelet aggregation, reliably and relatively simple, led to an exponential increase in the scientific interest on the subject. Considering just the PubMed da…
Anticoagulation with heparin is indicated in several situations, such as acute coronary disease (in combination with antiplatelet therapy) for the prevention and treatment of venous thromboembolism and situations with high risk of thromboembolism, such as atrial fibrillation, hemodialysis and invasive procedures such as radiofrequency ablation, among others. However some studies about in…
Study population: 100 patients with prior Ischemic Stroke or Transient Ischemic Attack, previous hospitalization due to Acute Coronary Syndrome (unstable angina, non-ST elevation or ST-elevation myocardial infarction), current use of ASA. Exclusion Criteria: Previously known hemorrhagic stroke; use of another antiplatelet agent than ASA; use of NSAIDs and / or dipyridamole; known platel…
Study population: 100 pacientes com Doença Arterial Coronária crônica selecionados do ambulatório da UCCA 100 patients with Stable Coronary Artery Disease from the Heart Institute Inclusion Criteria: Age > 18 years old; coronary artery disease, defined as previous myocardial infarction and/or coronary angioplasty and/or CABG surgery and/or coronariography showing obstruction of at least …
(Only some records are available in English at this moment)
There is evidence that platelets participate from the beginning of the atherosclerotic process (pre-clinical stage) to late stage of Coronary Disease, in which rupture or erosion of atherosclerotic plaque occurs, with consequent development of some form of Acute Coronary Syndromes(ACS): a) platelets may be involved in Atherosclerosis and formation of the foam cell, even in the absence of …
It is known that in comparison to clopidogrel, ticagrelor shows significant benefit regarding ischemic events and mortality. The importance of these findings, to some extent unexpected, raised the hypothesis that other properties of the medication could be partially responsible for these benefits. Recently, ticagrelor has been shown to be associated with increased adenosine plasma levels …
The association between diabetes and platelet reactivity is well known and a recent publication has shown that the recurrence of thrombotic events in the month following acute coronary syndrome treated with percutaneous coronary intervention is four times higher in the diabetic than in the non-diabetic population. The effect of oral hypoglycemic treatment on the acute phase of myocardial …
(Only some records are available in English at this moment)
| 2 / 2 | Ongoing research grants |
| 8 / 5 | Completed research grants |
| 9 / 7 | Completed scholarships in Brazil |
| 19 / 14 | All research grants and scholarships |
| Associated processes | |
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
| Publications | 4 |
| Citations | 8 |
| Cit./Article | 2.0 |
| Data from Web of Science | |
BERTOLIN, ADRIADNE J.; DALCOQUIO, TALIA F.; SALSOSO, ROCIO; DE M. FURTADO, REMO H.; KALIL-FILHO, ROBERTO; HAJJAR, LUDHMILA A.; SICILIANO, RINALDO F.; KALLAS, ESPER G.; BARACIOLI, LUCIANO M.; LIMA, FELIPE G.; et al. Platelet Reactivity and Coagulation Markers in Patients with COVID-19. ADVANCES IN THERAPY, v. 38, n. 7, JUN 2021. Web of Science Citations: 0. (20/04705-2)
GUTIERREZ, JAIME A.; GOMEZ, ISABEL; CHIARELLO, I, DELIA; SALSOSO, ROCIO; KLEIN, ANDRES D.; GUZMAN-GUTIERREZ, ENRIQUE; TOLEDO, FERNANDO; SOBREVIA, LUIS. Role of proteases in dysfunctional placental vascular remodelling in preeclampsia. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, v. 1866, n. 2, FEB 1 2020. Web of Science Citations: 1. (17/26922-2)
DELAFIORI, JEANY; NAVARRO, LUIZ CLAUDIO; SICILIANO, RINALDO FOCACCIA; DE MELO, GISELY CARDOSO; BRANDT BUSANELLO, ESTELA NATACHA; NICOLAU, JOSE CARLOS; SALES, GEOVANA MANZAN; DE OLIVEIRA, ARTHUR NOIN; ALMEIDA VAL, FERNANDO FONSECA; DE OLIVEIRA, DIOGO NOIN; et al. Covid-19 Automated Diagnosis and Risk Assessment through Metabolomics and Machine Learning. Analytical Chemistry, v. 93, n. 4, p. 2471-2479, FEB 2 2021. Web of Science Citations: 4. (19/05718-3, 17/12646-3, 20/05369-6, 20/04705-2, 18/10052-1)
SALSOSO, ROCIO; DALCOQUIO, TALIA F.; FURTADO, REMO H. M.; FRANCI, ANDRE; BARBOSA, CARLOS J. D. G.; GENESTRETI, PAULO R. R.; STRUNZ, CELIA M. C.; LIMA, VIVIANE; BARACIOLI, LUCIANO M.; GIUGLIANO, ROBERT P.; et al. Relation of High Lipoprotein (a) Concentrations to Platelet Reactivity in Individuals with and Without Coronary Artery Disease. ADVANCES IN THERAPY, SEP 2020. Web of Science Citations: 0. (14/01021-4, 14/03742-0, 17/26922-2)
BERTOLIN, ADRIADNE J.; DALCOQUIO, TALIA F.; SALSOSO, ROCIO; DE M. FURTADO, REMO H.; KALIL-FILHO, ROBERTO; HAJJAR, LUDHMILA A.; SICILIANO, RINALDO F.; KALLAS, ESPER G.; BARACIOLI, LUCIANO M.; LIMA, FELIPE G.; et al. Platelet Reactivity and Coagulation Markers in Patients with COVID-19. ADVANCES IN THERAPY, v. 38, n. 7, p. 3911-3923, JUL 2021. Web of Science Citations: 1. (20/04705-2)
SALSOSO, ROCIO; MATE, ALFONSO; TOLEDO, FERNANDO; VAZQUEZ, CARMEN M.; SOBREVIA, LUIS. Insulin requires A(2B) adenosine receptors to modulate the L-arginine/nitric oxide signalling in the human fetoplacental vascular endothelium from late-onset preeclampsia. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, v. 1867, n. 1, JAN 1 2021. Web of Science Citations: 0. (17/26922-2)
DE MENDONCA FURTADO, REMO HOLANDA; GIUGLIANO, ROBERT PATRICK; CASSARO STRUNZ, CELIA MARIA; CAVALHEIRO FILHO, CYRILLO; FRANCHINI RAMIRES, JOSE ANTONIO; KALIL FILHO, ROBERTO; LEMOS NETO, PEDRO ALVES; PEREIRA, ALEXANDRE COSTA; ROCHA, TANIA RUBIA; FREIRE, BEATRIZ TONON; et al. Drug Interaction Between Clopidogrel and Ranitidine or Omeprazole in Stable Coronary Artery Disease: A Double-Blind, Double Dummy, Randomized Study. American Journal of Cardiovascular Drugs, v. 16, n. 4, p. 275-284, AUG 2016. Web of Science Citations: 7. (10/16324-1)